Skip to main content
SpringerLink
Log in

Attention-Deficit Hyperactivity Disorder (ADHD) Treatment and Sudden Death

  • Commentary
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Nissen SE. ADHD drugs and cardiovascular risk. N Engl J Med 2006; 354(14): 1445–8

    Article  PubMed  CAS  Google Scholar 

  2. Anders T, Sharfstein S. ADHD drugs and cardiovascular risk [comment]. N Engl J Med 2006; 354(21): 2296–8

    Article  PubMed  CAS  Google Scholar 

  3. Rappley MD, Moore JW, Dokken D. ADHD drugs and cardiovascular risk [comment]. N Engl J Med 2006; 354(21): 2296–8

    Article  PubMed  CAS  Google Scholar 

  4. Wilens TE, Prince JB, Spencer TJ, et al. Stimulants and sudden death: what is a physician to do? Pediatrics 2006; 118(3): 1215–9

    Article  PubMed  Google Scholar 

  5. Gould MS, Walsh T, Munfakh JL, et al. Sudden death and use of stimulant medications in youths [online]. Available from URL: http://ajp.psychiatryonline.org/cgi/reprint/ajp;166/9/992 [Accessed 2009 Aug 28]

  6. US FDA. Communication about an ongoing safety review of stimulant medications used in children with attention-deficit/hyperactivity disorder (ADHD) [online]. Available from URL: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm165858.htm [Accessed 2009 Aug 28]

  7. McCarthy S, Cranswick N, Potts L, et al. Mortality associated with attention-deficit hyperactivity disorder (ADHD) drug treatment: a retrospective cohort study of children, adolescents and young adults using the General Practice Research Database. Drug Saf 2009; 32(11): 1089–96

    Article  PubMed  Google Scholar 

  8. George AK, Kunwar AR, Awasthi A. Acute myocardial infarction in a young male on methylphenidate, bupropion, and erythromycin. J Child Adolesc Psychopharmacol 2005; 15(4): 693–5

    Article  PubMed  Google Scholar 

  9. Gandhi PJ, Ezeala GU, Luyen TT, et al. Myocardial infarction in an adolescent taking Adderall. Am J Health Syst Pharm 2005; 62(14): 1494–7

    Article  PubMed  Google Scholar 

  10. Kanner AM. Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment. Biol Psychiatry 2003; 54(3): 388–98

    Article  PubMed  Google Scholar 

  11. Dopheide JA, Pliszka SR. Attention-deficit-hyperactivity disorder: an update. Pharmacotherapy 2009; 29(6): 656–79

    Article  PubMed  Google Scholar 

  12. Wilens TE, Faraone SV, Biederman J, et al. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 2003; 111(1): 179–85

    Article  PubMed  Google Scholar 

  13. Volkow ND, Swanson JM. Does childhood treatment of ADHD with stimulant medication affect substance abuse in adulthood? [comment]. Am J Psychiatry 2008; 165(5): 553–5

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Frank Besag has received lecture fees, consultancy fees, research grants and equipment grants from, and has been sponsored to attend conferences by, various pharmaceutical companies. He was previously Editor-in-Chief of a journal sponsored by GlaxoSmithKline. He is currently receiving no monies from pharmaceutical companies, nor from any source other than his employer, the NHS in the UK. There are no current conflicts of interest. No funding was received to support the preparation of this commentary.

Author information

Authors and Affiliations

  1. Bedfordshire & Luton Partnership NHS Trust, Milton Road, Bedford, MK41 6AT, UK

    Frank M.C. Besag

Authors
  1. Frank M.C. Besag
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Frank M.C. Besag.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Besag, F.M. Attention-Deficit Hyperactivity Disorder (ADHD) Treatment and Sudden Death. Drug-Safety 32, 1097–1100 (2009). https://doi.org/10.2165/11530340-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11530340-000000000-00000

Keywords

Search

Navigation